IPR Estoppel Does Not Bar Commission Investigative Staff from Asserting Prior Art References in an ITC Investigation

Oct 15, 2018

Reading Time : 1 min

The estoppel provision of 35 U.S.C. § 315(e)(2) prohibits the “petitioner . . .[,] real party in interest or privy of the petitioner” from raising grounds of invalidity that were “raised or reasonably could have [been] raised, during [IPR]” in a district court litigation or an investigation before the ITC.   

Prior to the instant ITC investigation, respondent Fujifilm had petitioned for IPR of one of Sony’s patents. The PTAB instituted review of the patent, but determined (in its final written decision) that it was not unpatentable. In the ITC investigation, Sony asserted the same patent against Fujifilm and contended that Fujifilm was estopped from relying on prior art references asserted in the IPR.

Sony also went one step further by arguing that the Commission Investigative Staff were estopped from asserting Fujifilm’s IPR references. In response, the Staff argued that 35 U.S.C. § 315(e)(2) “only estops the petitioner in an inter partes review,” and further that it was not a petitioner or even a party to the IPR. The ALJ found the Staff’s argument persuasive and held that “Regardless of whether 35 U.S.C. § 315(e)(2) estops Fujifilm, as contended by Sony, the statute does not prevent Staff from raising the references in this investigation, which it did.”  With the estoppel issue resolved, ALJ Cheney addressed the prior art references and found the asserted claims of the Sony patent invalid for anticipation and obviousness.  

Practice Tip:  Patent owners should be cognizant that, in ITC investigations, the estoppel provision of 35 U.S.C. § 315(e)(2) has been interpreted as being strictly limited to the petitioner, the real parties-in-interest or privies of the petitioner—but not encompassing the Commission Investigative Staff. This leaves open the possibility of the Staff raising invalidity challenges that have been previously rejected by the PTAB.

In the Matter of Certain Magnetic Tape Cartridges and Components Thereof, 337-TA-1058 (ITC October 2, 2018, Order) (Cheney, ALJ).

Share This Insight

Previous Entries

IP Newsflash

July 22, 2026

The Court of Federal Claims recently denied the United States’ motion to dismiss a patent infringement suit related to production of a COVID-19 vaccine. The court held that it had jurisdiction because the plaintiff filed its claim there before it filed a parallel suit in a district court and because it adequately pleaded the government’s involvement.

...

Read More

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.